CPT Dermatophagoides pteronyssinus LETI 100 HEP/ml clinical trials

A multicenter, double-blind, placebo-controlled, clinical trial to evaluate the efficacy and safety of two concentrations of a mixture of depigmented polymerized allergenic extracts of D. pteronyssinus and D. farinae, in patients suffering from allergic rhinoconjunctivitis with or without controlled asthma

This study looks at new treatments for allergies caused by dust mites, which can make your nose and eyes itchy and watery, and sometimes affect your breathing. We want to see if these treatments are safe and effective in reducing your symptoms.